Phase I study of TP300 in patients with advanced solid tumors with pharmacokinetic, pharmacogenetic and pharmacodynamic analyses
Anthoney, D Alan, Naik, Jay, Macpherson, Iain R J, Crawford, Donna, Hartley, John M, Hartley, Janet A, Saito, Tomohisa, Abe, Masaichi, Jones, Keith, Miwa, Masanori, Twelves, Christopher, Evans, T R J
Published in BMC cancer (21.11.2012)
Published in BMC cancer (21.11.2012)
Get full text
Journal Article
Abstract LB-200: Evidence of efficacy of antibody directed enzyme prodrug therapy (ADEPT) in a Phase I trial in patients with advanced carcinoma
Wilkins, Duncan K, Mayer, Astrid, Sharma, Surinder K, Tolner, Berend, Francis, Roslyn J, Springer, Caroline J, Hartley, Janet A, Boxer, Geoff M, Bell, James, Green, Alan J, Parker, Sweta, Griffin, Natalie, Shahbakhti, Hassan, Grudus, Edward, Chester, Kerry A, Begent, Richard H
Published in Cancer research (Chicago, Ill.) (15.05.2008)
Published in Cancer research (Chicago, Ill.) (15.05.2008)
Get full text
Journal Article